Αποτελέσματα Αναζήτησης
4 Οκτ 2022 · General issues related to antimicrobial resistance and treatment of CoNS infections will be reviewed here. Issues related to treatment of Staphylococcus lugdunensis are discussed separately. (See "Staphylococcus lugdunensis" .)
29 Αυγ 2022 · Coagulase-negative staphylococci (CoNS) are among the most frequent constituents of normal skin flora [1,2]. These organisms are increasingly recognized as agents of clinically significant infection, including bacteremia and endocarditis [3].
4 Οκτ 2022 · General discussions related to the diagnosis and treatment of infective endocarditis and to the epidemiology, microbiology, pathogenesis, and antibiotic resistance patterns of CoNS are presented separately.
16 Φεβ 2024 · Antibiotic resistance is a serious treatment-related complication of CoNS. Coagulase-negative staphylococci often are resistant to oxacillin/methicillin, penicillin, ciprofloxacin, gentamicin, erythromycin, and clindamycin, which requires the use of second-line antibiotics such as linezolid, vancomycin, or daptomycin. 10 While the optimal ...
14 Απρ 2021 · Coagulase-negative staphylococci (CoNS) are among the most frequently recovered bacteria in routine clinical care. Their incidence has steadily increased over the past decades in parallel to...
The definition of the heterogeneous group of coagulase-negative staphylococci (CoNS) is still based on diagnostic procedures that fulfill the clinical need to differentiate between Staphylococcus aureus and those staphylococci classified historically as being less or nonpathogenic.
4 Ιουν 2020 · The definition of CoNS as a heterogeneous group of staphylococci is based on diagnostic procedures that fulfil the clinical need to differentiate between Staphylococcus aureus, commonly known as strongly pathogenic, and other staphylococci classified as non- or less pathogenic .
